BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

513 related articles for article (PubMed ID: 22017583)

  • 1. The pathogenesis of mixed-lineage leukemia.
    Muntean AG; Hess JL
    Annu Rev Pathol; 2012; 7():283-301. PubMed ID: 22017583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular biology of mixed lineage leukemia.
    Slany RK
    Haematologica; 2009 Jul; 94(7):984-93. PubMed ID: 19535349
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Britten O; Ragusa D; Tosi S; Kamel YM
    Cells; 2019 Oct; 8(11):. PubMed ID: 31671855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring of post-transplant MLL-PTD as minimal residual disease can predict relapse after allogeneic HSCT in patients with acute myeloid leukemia and myelodysplastic syndrome.
    Kong J; Gao MG; Qin YZ; Wang Y; Yan CH; Sun YQ; Chang YJ; Xu LP; Zhang XH; Liu KY; Huang XJ; Zhao XS
    BMC Cancer; 2022 Jan; 22(1):11. PubMed ID: 34979982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The MLL gene and translocations involving chromosomal band 11q23 in acute leukemia.
    De Braekeleer M; Morel F; Le Bris MJ; Herry A; Douet-Guilbert N
    Anticancer Res; 2005; 25(3B):1931-44. PubMed ID: 16158928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MLL: a histone methyltransferase disrupted in leukemia.
    Hess JL
    Trends Mol Med; 2004 Oct; 10(10):500-7. PubMed ID: 15464450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia.
    Armstrong SA; Staunton JE; Silverman LB; Pieters R; den Boer ML; Minden MD; Sallan SE; Lander ES; Golub TR; Korsmeyer SJ
    Nat Genet; 2002 Jan; 30(1):41-7. PubMed ID: 11731795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 11q23 rearrangements in acute leukemia.
    Rubnitz JE; Behm FG; Downing JR
    Leukemia; 1996 Jan; 10(1):74-82. PubMed ID: 8558942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of embryonic and adult leukemia mouse models driven by MLL-ENL translocation.
    Sinha R; Porcheri C; d'Altri T; González J; Ruiz-Herguido C; Rabbitts T; Espinosa L; Bigas A
    Exp Hematol; 2020 May; 85():13-19. PubMed ID: 32437911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse models of MLL leukemia: recapitulating the human disease.
    Milne TA
    Blood; 2017 Apr; 129(16):2217-2223. PubMed ID: 28179274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal rearrangements leading to MLL gene fusions: clinical and biological aspects.
    Harper DP; Aplan PD
    Cancer Res; 2008 Dec; 68(24):10024-7. PubMed ID: 19074864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analyzing acute leukemia patients with complex MLL rearrangements by a sequential LDI-PCR approach.
    Binato R; Meyer C; Macedo-Silva ML; Garcia D; Figueiredo A; Hofmann J; Vieira TP; Abdelhay E; Marschalek R
    Cancer Lett; 2013 Sep; 338(2):249-54. PubMed ID: 23562474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relatively favorable prognosis for MLL-rearranged childhood acute leukemia with reciprocal translocations.
    Yang L; Ding L; Liang J; Chen J; Tang Y; Xue H; Gu L; Shen S; Li B; Chen J
    Pediatr Blood Cancer; 2018 Oct; 65(10):e27266. PubMed ID: 29943896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MLL recombinome of acute leukemias in 2017.
    Meyer C; Burmeister T; Gröger D; Tsaur G; Fechina L; Renneville A; Sutton R; Venn NC; Emerenciano M; Pombo-de-Oliveira MS; Barbieri Blunck C; Almeida Lopes B; Zuna J; Trka J; Ballerini P; Lapillonne H; De Braekeleer M; Cazzaniga G; Corral Abascal L; van der Velden VHJ; Delabesse E; Park TS; Oh SH; Silva MLM; Lund-Aho T; Juvonen V; Moore AS; Heidenreich O; Vormoor J; Zerkalenkova E; Olshanskaya Y; Bueno C; Menendez P; Teigler-Schlegel A; Zur Stadt U; Lentes J; Göhring G; Kustanovich A; Aleinikova O; Schäfer BW; Kubetzko S; Madsen HO; Gruhn B; Duarte X; Gameiro P; Lippert E; Bidet A; Cayuela JM; Clappier E; Alonso CN; Zwaan CM; van den Heuvel-Eibrink MM; Izraeli S; Trakhtenbrot L; Archer P; Hancock J; Möricke A; Alten J; Schrappe M; Stanulla M; Strehl S; Attarbaschi A; Dworzak M; Haas OA; Panzer-Grümayer R; Sedék L; Szczepański T; Caye A; Suarez L; Cavé H; Marschalek R
    Leukemia; 2018 Feb; 32(2):273-284. PubMed ID: 28701730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and molecular biologic characteristics of 36 cases of leukemia with 11q23/mll].
    Zhao J; Yin YM; Zhao YL; Sun Y; Wang JB; Zhong J; Zhang X; Fei XH; Shan FX; Liu HX; Wang T; Wang H; Tong CR; Wu T; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Dec; 18(6):1381-5. PubMed ID: 21176334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignant hematopoietic cell lines: in vitro models for the study of MLL gene alterations.
    Drexler HG; Quentmeier H; MacLeod RA
    Leukemia; 2004 Feb; 18(2):227-32. PubMed ID: 14671638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.
    Driessen EM; van Roon EH; Spijkers-Hagelstein JA; Schneider P; de Lorenzo P; Valsecchi MG; Pieters R; Stam RW
    Haematologica; 2013 Jun; 98(6):937-44. PubMed ID: 23403319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-based RT-PCR methods for the detection of the 8 most common MLL aberrations in acute leukemias.
    Burmeister T; Meyer C; Gröger D; Hofmann J; Marschalek R
    Leuk Res; 2015 Feb; 39(2):242-7. PubMed ID: 25510485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seminars from the University of Minnesota. Chromosome translocations: dangerous liaisons.
    Rowley JD
    J Lab Clin Med; 1998 Oct; 132(4):244-50. PubMed ID: 9794694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAS mutations in pediatric leukemias with MLL gene rearrangements.
    Mahgoub N; Parker RI; Hosler MR; Close P; Winick NJ; Masterson M; Shannon KM; Felix CA
    Genes Chromosomes Cancer; 1998 Mar; 21(3):270-5. PubMed ID: 9523205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.